As part of the nationwide filariasis eradication initiative, Bharat Coking Coal Limited (BCCL) organised a Mass Drug Administration (MDA) campaign at Bhuli Regional Hospital, reinforcing its commitment to community healthcare and disease prevention.
During the campaign, anti-filariasis medicines, including Diethylcarbamazine (DEC) and Albendazole tablets, were administered and distributed free of cost to over 200 beneficiaries, including local residents, BCCL employees, their families, and other citizens.
In addition to the drug distribution drive, a special health camp was organised to spread awareness about diabetes and hypertension. Beneficiaries underwent free blood pressure and hypertension screenings, while specialist doctors provided medical consultations and necessary guidance.
The programme was presided over by Director (Human Resources), Mr. Murali Krishna Ramaiah. Among those present were General Manager (Administration) Mr. Arpan Ghosh, Head of Department (Welfare) Mrs. Kiran Rani Nayak, Medical Officer (Bhuli RH) Dr. Abhijit Kumar, along with other doctors, paramedical and nursing staff, officers, and employees of Bhuli Regional Hospital.
Mr. Prem Narayan Singh, Mr. Vinod Singh, and other hospital staff played a key role in ensuring the smooth execution of the programme.
It is noteworthy that under the guidance of the district administration, the filariasis eradication campaign is being conducted across the district from February 11 to February 25, 2026. As part of this drive, health workers are undertaking door-to-door distribution of medicines to ensure maximum coverage. In continuation of this effort, the Bhuli Regional Hospital team also carried out large-scale medicine distribution during the day.
The initiative highlights BCCL’s sustained efforts towards preventive healthcare and community welfare in its operational areas.
